Theravance Biopharma (TBPH) Gross Profit Growth (3y) (2016 - 2018)
Theravance Biopharma (TBPH) Gross Profit Growth (3y) (2016 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 9.20% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.09% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 299.84% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 45.27% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 803.34% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 59.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 80.79% |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 179.47% |
| Sep 30, 2018 | 6.24% |
| Jun 30, 2018 | 49.23% |
| Mar 31, 2018 | -27.95% |
| Dec 31, 2017 | 47.94% |
| Sep 30, 2017 | -18.00% |
| Jun 30, 2017 | -7.33% |
| Mar 31, 2017 | 49.35% |
| Dec 31, 2016 | 196.16% |
| Sep 30, 2016 | 820.89% |
| Jun 30, 2016 | 1,321.50% |
| Mar 31, 2016 | 828.88% |